TY - JOUR
T1 - Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region.
AU - Lynch, Peter J.
N1 - Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2004
Y1 - 2004
N2 - Lichen simplex chronicus (LSC) of the anogenital area is an eczematous disease characterized by unremitting itching and scratching. In most instances, it arises in individuals who are genetically atopic, and as such, LSC can be viewed as a localized variant of atopic/neurodermatitis. Common triggers for the development of the disease include psychological distress, and local environmental problems such as heat, sweating, and excess dryness. Lichen simplex chronicus may also develop as a superimposed condition in the presence of other anogenital diseases such as candidiasis, psoriasis, lichen sclerosus, tinea cruris, and neoplasia. Lichen simplex chronicus frequently persists as an itch-scratch cycle, even when environmental triggers are removed and the underlying disease is treated. For this reason, successful therapy requires attention not only to trigger factors, but also to repair of the damaged barrier layer, reduction in inflammation, and breakup of the itch-scratch cycle.
AB - Lichen simplex chronicus (LSC) of the anogenital area is an eczematous disease characterized by unremitting itching and scratching. In most instances, it arises in individuals who are genetically atopic, and as such, LSC can be viewed as a localized variant of atopic/neurodermatitis. Common triggers for the development of the disease include psychological distress, and local environmental problems such as heat, sweating, and excess dryness. Lichen simplex chronicus may also develop as a superimposed condition in the presence of other anogenital diseases such as candidiasis, psoriasis, lichen sclerosus, tinea cruris, and neoplasia. Lichen simplex chronicus frequently persists as an itch-scratch cycle, even when environmental triggers are removed and the underlying disease is treated. For this reason, successful therapy requires attention not only to trigger factors, but also to repair of the damaged barrier layer, reduction in inflammation, and breakup of the itch-scratch cycle.
UR - http://www.scopus.com/inward/record.url?scp=2342436685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342436685&partnerID=8YFLogxK
U2 - 10.1111/j.1396-0296.2004.04002.x
DO - 10.1111/j.1396-0296.2004.04002.x
M3 - Review article
C2 - 14756886
AN - SCOPUS:2342436685
SN - 1396-0296
VL - 17
SP - 8
EP - 19
JO - Dermatologic therapy
JF - Dermatologic therapy
IS - 1
ER -